Logo image of ALGN

ALIGN TECHNOLOGY INC (ALGN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALGN - US0162551016 - Common Stock

157.21 USD
+0.37 (+0.24%)
Last: 12/5/2025, 8:02:47 PM
157.21 USD
0 (0%)
After Hours: 12/5/2025, 8:02:47 PM
Fundamental Rating

6

Taking everything into account, ALGN scores 6 out of 10 in our fundamental rating. ALGN was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ALGN a very profitable company, without any liquidiy or solvency issues. ALGN scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings would make ALGN suitable for value and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ALGN had positive earnings in the past year.
In the past year ALGN had a positive cash flow from operations.
In the past 5 years ALGN has always been profitable.
ALGN had a positive operating cash flow in each of the past 5 years.
ALGN Yearly Net Income VS EBIT VS OCF VS FCFALGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

ALGN has a better Return On Assets (6.07%) than 83.60% of its industry peers.
With an excellent Return On Equity value of 9.57%, ALGN belongs to the best of the industry, outperforming 84.66% of the companies in the same industry.
ALGN's Return On Invested Capital of 10.50% is amongst the best of the industry. ALGN outperforms 90.48% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALGN is above the industry average of 8.78%.
Industry RankSector Rank
ROA 6.07%
ROE 9.57%
ROIC 10.5%
ROA(3y)6.72%
ROA(5y)13.99%
ROE(3y)11.08%
ROE(5y)21.89%
ROIC(3y)11.25%
ROIC(5y)11.65%
ALGN Yearly ROA, ROE, ROICALGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

The Profit Margin of ALGN (9.51%) is better than 82.01% of its industry peers.
In the last couple of years the Profit Margin of ALGN has declined.
ALGN's Operating Margin of 16.23% is amongst the best of the industry. ALGN outperforms 86.24% of its industry peers.
ALGN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 69.48%, ALGN is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
In the last couple of years the Gross Margin of ALGN has remained more or less at the same level.
Industry RankSector Rank
OM 16.23%
PM (TTM) 9.51%
GM 69.48%
OM growth 3Y-12.06%
OM growth 5Y-4.71%
PM growth 3Y-18.59%
PM growth 5Y-10.55%
GM growth 3Y-1.95%
GM growth 5Y-0.69%
ALGN Yearly Profit, Operating, Gross MarginsALGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALGN is creating some value.
ALGN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ALGN has been reduced compared to 5 years ago.
There is no outstanding debt for ALGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALGN Yearly Shares OutstandingALGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALGN Yearly Total Debt VS Total AssetsALGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

ALGN has an Altman-Z score of 4.61. This indicates that ALGN is financially healthy and has little risk of bankruptcy at the moment.
ALGN's Altman-Z score of 4.61 is fine compared to the rest of the industry. ALGN outperforms 77.25% of its industry peers.
There is no outstanding debt for ALGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.61
ROIC/WACC1.2
WACC8.78%
ALGN Yearly LT Debt VS Equity VS FCFALGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

ALGN has a Current Ratio of 1.29. This is a normal value and indicates that ALGN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALGN (1.29) is worse than 80.42% of its industry peers.
A Quick Ratio of 1.17 indicates that ALGN should not have too much problems paying its short term obligations.
ALGN has a Quick ratio of 1.17. This is in the lower half of the industry: ALGN underperforms 69.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.17
ALGN Yearly Current Assets VS Current LiabilitesALGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

ALGN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.76%.
ALGN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.91% yearly.
The Revenue has been growing slightly by 0.56% in the past year.
ALGN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.69% yearly.
EPS 1Y (TTM)3.76%
EPS 3Y-5.96%
EPS 5Y11.91%
EPS Q2Q%11.06%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y0.39%
Revenue growth 5Y10.69%
Sales Q2Q%1.82%

3.2 Future

The Earnings Per Share is expected to grow by 10.83% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.37% on average over the next years.
EPS Next Y11.47%
EPS Next 2Y9.3%
EPS Next 3Y9.02%
EPS Next 5Y10.83%
Revenue Next Year0.51%
Revenue Next 2Y1.95%
Revenue Next 3Y2.85%
Revenue Next 5Y6.37%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALGN Yearly Revenue VS EstimatesALGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
ALGN Yearly EPS VS EstimatesALGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

ALGN is valuated correctly with a Price/Earnings ratio of 16.26.
86.24% of the companies in the same industry are more expensive than ALGN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.46, ALGN is valued a bit cheaper.
A Price/Forward Earnings ratio of 14.09 indicates a correct valuation of ALGN.
Based on the Price/Forward Earnings ratio, ALGN is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.10, ALGN is valued rather cheaply.
Industry RankSector Rank
PE 16.26
Fwd PE 14.09
ALGN Price Earnings VS Forward Price EarningsALGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

84.66% of the companies in the same industry are more expensive than ALGN, based on the Enterprise Value to EBITDA ratio.
ALGN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALGN is cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.91
EV/EBITDA 13.49
ALGN Per share dataALGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ALGN may justify a higher PE ratio.
PEG (NY)1.42
PEG (5Y)1.36
EPS Next 2Y9.3%
EPS Next 3Y9.02%

0

5. Dividend

5.1 Amount

ALGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALIGN TECHNOLOGY INC

NASDAQ:ALGN (12/5/2025, 8:02:47 PM)

After market: 157.21 0 (0%)

157.21

+0.37 (+0.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners97.81%
Inst Owner Change4.38%
Ins Owners0.69%
Ins Owner Change1.24%
Market Cap11.28B
Revenue(TTM)3.98B
Net Income(TTM)378.59M
Analysts77.39
Price Target184.44 (17.32%)
Short Float %4.48%
Short Ratio2.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.79%
Min EPS beat(2)-4.95%
Max EPS beat(2)6.53%
EPS beat(4)2
Avg EPS beat(4)1.18%
Min EPS beat(4)-4.95%
Max EPS beat(4)6.53%
EPS beat(8)5
Avg EPS beat(8)2.84%
EPS beat(12)8
Avg EPS beat(12)3.11%
EPS beat(16)9
Avg EPS beat(16)-1.08%
Revenue beat(2)0
Avg Revenue beat(2)-3.18%
Min Revenue beat(2)-6.34%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-6.34%
Max Revenue beat(4)-0.02%
Revenue beat(8)2
Avg Revenue beat(8)-1.81%
Revenue beat(12)3
Avg Revenue beat(12)-1.6%
Revenue beat(16)3
Avg Revenue beat(16)-2.32%
PT rev (1m)2.68%
PT rev (3m)-3.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.4%
EPS NY rev (1m)0.27%
EPS NY rev (3m)1.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 16.26
Fwd PE 14.09
P/S 2.83
P/FCF 19.91
P/OCF 17.19
P/B 2.85
P/tB 3.35
EV/EBITDA 13.49
EPS(TTM)9.67
EY6.15%
EPS(NY)11.16
Fwd EY7.1%
FCF(TTM)7.9
FCFY5.02%
OCF(TTM)9.14
OCFY5.82%
SpS55.51
BVpS55.16
TBVpS46.93
PEG (NY)1.42
PEG (5Y)1.36
Graham Number109.55
Profitability
Industry RankSector Rank
ROA 6.07%
ROE 9.57%
ROCE 15.14%
ROIC 10.5%
ROICexc 11.03%
ROICexgc 12.91%
OM 16.23%
PM (TTM) 9.51%
GM 69.48%
FCFM 14.22%
ROA(3y)6.72%
ROA(5y)13.99%
ROE(3y)11.08%
ROE(5y)21.89%
ROIC(3y)11.25%
ROIC(5y)11.65%
ROICexc(3y)12.85%
ROICexc(5y)14.58%
ROICexgc(3y)15.07%
ROICexgc(5y)17.6%
ROCE(3y)16.23%
ROCE(5y)16.81%
ROICexgc growth 3Y-21.83%
ROICexgc growth 5Y-25.54%
ROICexc growth 3Y-20.41%
ROICexc growth 5Y-25.98%
OM growth 3Y-12.06%
OM growth 5Y-4.71%
PM growth 3Y-18.59%
PM growth 5Y-10.55%
GM growth 3Y-1.95%
GM growth 5Y-0.69%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 51.62%
Cap/Sales 2.25%
Interest Coverage 250
Cash Conversion 80.04%
Profit Quality 149.64%
Current Ratio 1.29
Quick Ratio 1.17
Altman-Z 4.61
F-Score7
WACC8.78%
ROIC/WACC1.2
Cap/Depr(3y)145.51%
Cap/Depr(5y)194.24%
Cap/Sales(3y)5.1%
Cap/Sales(5y)6.34%
Profit Quality(3y)120.32%
Profit Quality(5y)97.89%
High Growth Momentum
Growth
EPS 1Y (TTM)3.76%
EPS 3Y-5.96%
EPS 5Y11.91%
EPS Q2Q%11.06%
EPS Next Y11.47%
EPS Next 2Y9.3%
EPS Next 3Y9.02%
EPS Next 5Y10.83%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y0.39%
Revenue growth 5Y10.69%
Sales Q2Q%1.82%
Revenue Next Year0.51%
Revenue Next 2Y1.95%
Revenue Next 3Y2.85%
Revenue Next 5Y6.37%
EBIT growth 1Y-4.86%
EBIT growth 3Y-11.72%
EBIT growth 5Y5.48%
EBIT Next Year25.54%
EBIT Next 3Y10.88%
EBIT Next 5Y11.14%
FCF growth 1Y-17.43%
FCF growth 3Y-6.89%
FCF growth 5Y0.82%
OCF growth 1Y-25.75%
OCF growth 3Y-14.29%
OCF growth 5Y-0.24%

ALIGN TECHNOLOGY INC / ALGN FAQ

What is the ChartMill fundamental rating of ALIGN TECHNOLOGY INC (ALGN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALGN.


What is the valuation status of ALIGN TECHNOLOGY INC (ALGN) stock?

ChartMill assigns a valuation rating of 7 / 10 to ALIGN TECHNOLOGY INC (ALGN). This can be considered as Undervalued.


Can you provide the profitability details for ALIGN TECHNOLOGY INC?

ALIGN TECHNOLOGY INC (ALGN) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ALGN stock?

The Price/Earnings (PE) ratio for ALIGN TECHNOLOGY INC (ALGN) is 16.26 and the Price/Book (PB) ratio is 2.85.